Johan Schultz
Karolinska Institutet Science Park
Solna, AB 17165, Sweden
Solna, AB 17165, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL).
Journal: Cancers
Published: September 20, 2024
A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells.
Journal: Pharmaceutics
Published: February 27, 2023
Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules.
Journal: Handbook of experimental pharmacology
Published: September 07, 2021
Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2.
Journal: Cell reports
Published: July 06, 2021
Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung.
Journal: Cell death & disease
Published: July 30, 2020
ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.
Journal: Biomedicines
Published: May 14, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer.
Journal: Cancers
Published: November 19, 2019
Identification of novel quinazoline derivatives as potent antiplasmodial agents.
Journal: European journal of medicinal chemistry
Published: August 16, 2018
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.
Journal: PloS one
Published: February 28, 2018
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination.
Journal: Nature communications
Published: February 09, 2018
Last Updated: 09/26/2026